QNTM
Quantum BioPharma·NASDAQ
--
--(--)
--
--(--)
QNTM fundamentals
During Q3 2025, Quantum BioPharma (QNTM) reported revenue of --, a YoY change of 0.00%. Net income was -4.75M, a YoY change of -18.24%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 20.73K -- | -- -- | 22.35K -- | 10.71K -- | 4.09K -80.29% | 13.85K -- | 14.13K -36.78% | 9.67K -9.68% | 159.92K +3813.89% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | 20.73K -- | -- -- | 22.35K -- | 10.71K -- | -60.97K -394.17% | 13.85K -- | 14.13K -36.78% | 9.67K -9.68% | 159.92K +362.30% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 742.22K -- | 1.16M -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | 20.73K -- | -- -- | 22.35K -- | 10.71K -- | -60.97K -394.17% | 13.85K -- | 14.13K -36.78% | -732.55K -6943.03% | -1.00M -1542.88% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 10.52K -- | 17.95K -- | 61.88K -- | 336.97K -- | 2.75M +26041.79% | 1.58M +8693.37% | 2.01M +3144.31% | 14.00M +4055.81% | 2.43M -11.45% | 3.37M +113.58% | 4.23M +110.52% | 16.34M +16.66% | 6.68M +174.54% | 4.83M +43.26% | 13.16M +211.26% | 6.02M -63.14% | 9.80M +46.64% | 12.69M +162.77% | 5.13M -60.98% | 6.12M +1.61% | 5.65M -42.37% | 7.87M -38.01% | 7.25M +41.33% | 6.66M +8.84% | 9.84M +74.26% | 8.83M +12.27% | 3.31M -54.35% | 1.80M -72.96% | 2.26M -77.07% | 3.46M -60.86% | 4.18M +26.24% | 6.24M +246.52% | 3.40M +50.50% | 4.85M +40.41% | 4.68M +11.89% | 19.17M -- |
Selling, General and Administrative Expenses | -- -- | 1.85K -- | 28.01K -- | 119.42K -- | 44.38K -- | 411.62K +22165.14% | 425.54K +1419.09% | 12.90M +10704.06% | 526.42K +1086.26% | 1.99M +384.03% | 2.36M +455.03% | 8.06M -37.50% | 3.99M +657.43% | 2.90M +45.73% | 3.78M +59.90% | 12.10M +50.07% | 4.00M +0.32% | 6.06M +108.58% | 4.99M +32.15% | 12.37M +2.21% | 4.63M +15.74% | 6.10M +0.71% | 4.80M -3.80% | 4.99M -59.66% | 3.85M -16.91% | 2.98M -51.17% | 3.34M -30.33% | 1.59M -68.03% | 2.10M -45.48% | 2.56M -14.08% | 3.44M +2.73% | 1.96M +22.95% | 1.75M -16.60% | 4.30M +68.23% | 4.18M +21.73% | 12.20M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 10.06M -- | -- -- | -- -- | -- -- | 15.93M +58.34% | -- -- | -- -- | -- -- | 14.45M -9.27% | -- -- | -- -- | 3.07M -- | 1.37M -90.50% | 1.92M -- | 2.31M -- | 3.25M +5.80% | 1.93M +40.58% | 1.33M -30.80% | 3.31M +43.41% | 3.04M -6.42% | 9.61M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 303.39K -- | 1.56M -- | 3.51M -- | 2.46M -- | 1.97M +549.41% | 3.61M +131.36% | -107.26K -103.05% | 852.39K -65.29% | 937.05K -52.44% | 1.41M -60.91% | 1.87M +1840.41% | 2.69M +216.16% | 2.31M +146.69% | 1.61M +14.05% | -32.98K -101.77% | -29.96K -101.11% | 160.26K -93.07% | 897.99K -44.24% | 744.80K +2358.00% | 4.28M +14386.34% | 1.65M +928.55% | 549.20K -38.84% | 495.22K -33.51% | 6.97M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 89.86K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 236.19K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | 10.52K -- | 16.10K -- | 33.87K -- | 217.55K -- | 2.71M +25619.92% | 1.17M +7146.46% | 1.58M +4571.22% | 1.10M +406.54% | 1.91M -29.46% | 1.38M +18.16% | 1.86M +17.85% | 8.27M +650.71% | 2.39M +25.45% | 364.08K -73.59% | 5.87M +214.65% | -8.63M -204.26% | 3.83M +60.08% | 3.02M +729.67% | 249.19K -95.75% | -7.10M +17.66% | 83.16K -97.83% | 355.01K -88.25% | 586.51K +135.36% | -1.02M +85.57% | 3.69M +4333.12% | 4.24M +1095.17% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -10.52K -- | -17.95K -- | -61.88K -- | -316.24K -- | -2.75M -26041.79% | -1.56M -8568.83% | -2.00M -3127.01% | -14.06M -4347.46% | -2.42M +11.96% | -3.36M -115.74% | -4.96M -148.33% | -17.34M -23.27% | -6.68M -176.11% | -4.83M -43.86% | -13.16M -165.28% | -6.02M +65.27% | -9.80M -46.64% | -12.69M -162.77% | -5.13M +60.98% | -6.12M -1.61% | -5.65M +42.37% | -7.87M +38.01% | -7.25M -41.33% | -6.66M -8.84% | -9.84M -74.26% | -8.83M -12.27% | -3.31M +54.35% | -1.80M +72.96% | -2.26M +77.07% | -3.46M +60.86% | -4.18M -26.24% | -6.24M -246.52% | -3.40M -50.50% | -4.85M -40.41% | -4.68M -11.89% | -19.17M -- |
Non-Operating Income (Loss) | -- -- | -- -- | -2.39M -- | 0 -- | 31.02K -- | 4.65M -- | 4.98M +308.38% | -1.25M -- | 701.49K +2161.68% | -7.53M -261.86% | -7.61M -252.84% | 2.82M +325.21% | -1.48M -310.30% | 903.56K +112.01% | 752.79K +109.89% | 2.06M -27.01% | 397.04K +126.91% | -64.98K -107.19% | -482.20K -164.06% | -44.16K -102.15% | 188.84K -52.44% | -99.50K -53.12% | 125.28K +125.98% | 511.33K +1258.04% | -112.55K -159.60% | 3.34M +3457.95% | 2.18M +1640.67% | 149.56K -70.75% | 165.93K +247.42% | 104.11K -96.88% | 165.74K -92.40% | 784.95K +424.84% | -5.34M -3319.69% | -4.91M -4819.08% | -69.47K -141.92% | -9.54M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | 732.42K -- | -- -- | 35.72K -- | 386.12K -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.79M -- | -- -- | -- -- | -- -- | -175.98K -109.83% | -- -- | -- -- | -- -- | 287.58K +263.42% | -- -- | -- -- | -5.86K -- | -4.22K -101.47% | 23.30K -- | 8.04K -- | -74 +98.74% | -72.25K -1612.54% | -3.83M -16536.72% | -6.63M -82555.93% | -468.39K -632864.86% | -11.00M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -2.39M -- | 0 -- | 31.02K -- | 4.65M -- | 4.98M +308.38% | -1.25M -- | 701.49K +2161.68% | -7.52M -261.74% | -7.54M -251.28% | 2.89M +331.17% | -1.40M -299.87% | 972.04K +112.93% | 813.77K +110.80% | 296.40K -89.76% | 416.37K +129.70% | -46.06K -104.74% | -480.25K -159.01% | 161.03K -45.67% | 205.22K -50.71% | -85.47K -85.54% | 75.83K +115.79% | -76.13K -147.28% | -384.23K -287.23% | 3.16M +3791.56% | 2.01M +2553.39% | 0 +100.00% | -17.48K +95.45% | 0 -100.00% | 12.32K -99.39% | -5.42K -- | -1.56M -8816.47% | 1.71M -- | 3.95K -67.96% | 147.37K -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.53K -- | 77.40K -- | 74.61K -- | 73.16K -- | 68.47K +1137.77% | 60.98K -21.22% | 29.28K -60.76% | 19.32K -73.59% | 18.92K -72.37% | 1.96K -96.79% | 29.20K -0.24% | 16.38K -15.23% | 14.04K -25.81% | -49.45K -2626.67% | -299.88K -1126.82% | -271.67K -1758.37% | -186.16K -1426.42% | -174.45K -252.80% | -153.78K +48.72% | -160.11K +41.07% | -96.07K +48.40% | -153.50K +12.01% | -130.20K +15.33% | -45.05K +71.86% | 26.23K +127.30% | -8.85K +94.23% | -157.87K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.53K -- | 77.40K -- | 74.61K -- | 73.16K -- | 68.47K +1137.77% | 60.98K -21.22% | 32.97K -55.81% | 19.32K -73.59% | 18.92K -72.37% | 1.96K -96.79% | 29.20K -11.41% | 16.38K -15.23% | 16.25K -14.08% | 16.05K +720.24% | 135 -99.54% | 667 -95.93% | -- -- | -- -- | 12 -91.11% | 12.41K +1761.17% | 8.36K -- | 10.37K -- | 1.88K +15525.00% | 22.17K +78.57% | 116.96K +1299.57% | 91.57K +782.94% | 232.57K -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 3.69K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | 2.22K -- | 65.50K -- | 300.02K -- | 272.34K -- | 186.16K +8293.28% | 174.45K +166.34% | 153.79K -48.74% | 172.52K -36.65% | 104.42K -43.91% | 163.87K -6.06% | 132.07K -14.12% | 67.22K -61.04% | 90.73K -13.11% | 100.42K -38.72% | 390.44K -- |
Pretax Income From Continuing Operations | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.57M -521.22% | -14.52M +5.21% | -8.16M -374.54% | -3.93M +63.93% | -12.40M +1.36% | -3.96M +72.70% | -9.41M -15.27% | -12.75M -224.91% | -5.61M +54.73% | -6.16M -55.47% | -5.46M +41.94% | -7.97M +37.55% | -7.13M -26.97% | -6.15M +0.24% | -9.96M -82.34% | -5.49M +31.07% | -1.13M +84.13% | -1.65M +73.14% | -2.09M +79.00% | -3.35M +38.94% | -4.02M -254.96% | -5.46M -230.37% | -8.74M -317.89% | -9.77M -191.31% | -4.75M -18.24% | -28.71M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.20M -- | -566.93K -- | -1.16M -- | -414.12K -- | -533.84K +55.58% | -452.94K +20.11% | -176.10K +84.88% | -184.59K +55.43% | -444.51K +16.73% | 3.54M +881.86% | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.57M -521.22% | -14.52M +5.21% | -9.36M -444.44% | -4.49M +58.72% | -13.57M -7.91% | -4.38M +69.84% | -9.94M -6.17% | -13.21M -193.99% | -5.79M +57.32% | -6.35M -44.98% | -5.91M +40.59% | -4.42M +66.50% | -7.13M -23.10% | -6.15M +3.14% | -9.96M -68.62% | -5.49M -24.10% | -1.13M +84.13% | -1.65M +73.14% | -2.09M +79.00% | -3.35M +38.94% | -4.02M -254.96% | -5.46M -230.37% | -8.74M -317.89% | -9.77M -191.31% | -4.75M -18.24% | -28.71M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -71.36K -- | -257.05K -- | -188.05K -- | -240.58K -- | -188.16K -163.67% | -96.02K +62.65% | -163.16K +13.24% | -513.26K -113.34% | 571.43K +403.70% | -201.00K -- |
Net Income Attributable to Owners of the Company | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.57M -521.22% | -14.52M +5.21% | -9.36M -444.44% | -4.49M +58.72% | -13.57M -7.91% | -4.38M +69.84% | -9.94M -6.17% | -13.21M -193.99% | -5.79M +57.32% | -6.35M -44.98% | -5.91M +40.59% | -4.42M +66.50% | -7.13M -23.10% | -6.15M +3.14% | -9.96M -68.62% | -5.49M -24.10% | -1.06M +85.13% | -1.39M +77.32% | -1.90M +80.89% | -3.11M +43.32% | -3.83M -261.11% | -5.36M -284.38% | -8.58M -350.61% | -9.25M -197.34% | -5.32M -38.98% | -28.51M -- |
Net Income Attributable to Common Stockholders | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.57M -521.22% | -14.52M +5.21% | -9.36M -444.44% | -4.49M +58.72% | -13.57M -7.91% | -4.38M +69.84% | -9.94M -6.17% | -13.21M -193.99% | -5.79M +57.32% | -6.35M -44.98% | -5.91M +40.59% | -4.42M +66.50% | -7.13M -23.10% | -6.15M +3.14% | -9.96M -68.62% | -5.49M -24.10% | -1.06M +85.13% | -1.39M +77.32% | -1.90M +80.89% | -3.11M +43.32% | -3.83M -261.11% | -5.36M -284.38% | -8.58M -350.61% | -9.25M -197.34% | -5.32M -38.98% | -28.51M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 184.86K -- | -275.81K -- | 1.22M -- | -547.32K -- | -272.45K -247.38% | -105.61K +61.71% | -37.37K -103.07% | -41.95K +92.34% | 125.57K +146.09% | -14.44K +86.33% | -73.58K -96.91% | 124.57K +396.97% | 321.40K +155.95% | 40.60K +381.23% | 15.40K +120.93% | -232.89K -286.95% | 267.35K -16.82% | -285.12K -802.25% | -232.75K -1611.20% | -101.09K +56.59% | 749.56K +180.37% | -782.27K -174.36% | -3.49K +98.50% | 83.54K +182.64% | 145.30K -80.62% | -556.91K -- |
Total Comprehensive Income | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.39M -515.02% | -14.79M +3.41% | -8.14M -373.61% | -5.04M +53.69% | -13.84M -11.72% | -4.48M +69.69% | -9.98M -22.51% | -13.25M -162.89% | -5.67M +59.06% | -6.36M -41.89% | -5.98M +40.07% | -4.30M +67.55% | -6.81M -20.16% | -6.11M +4.00% | -9.94M -66.29% | -5.72M -33.11% | -863.85K +87.31% | -1.94M +68.29% | -2.32M +76.62% | -3.45M +39.66% | -3.27M -278.05% | -6.24M -222.12% | -8.74M -276.19% | -9.68M -180.37% | -4.60M -40.93% | -29.27M -- |
Total Comprehensive Income Attributable to Owners of the Company | -10.52K -- | -17.95K -- | -2.45M -- | -316.24K -- | -2.72M -25746.92% | 3.09M +17334.10% | 2.98M +221.70% | -15.32M -4743.31% | -1.72M +36.75% | -10.88M -451.79% | -12.39M -515.02% | -14.79M +3.41% | -8.14M -373.61% | -5.04M +53.69% | -13.84M -11.72% | -4.48M +69.69% | -9.98M -22.51% | -13.25M -162.89% | -5.67M +59.06% | -6.36M -41.89% | -5.98M +40.07% | -4.30M +67.55% | -6.81M -20.16% | -6.11M +4.00% | -9.94M -66.29% | -5.72M -33.11% | -863.85K +87.31% | -1.94M +68.29% | -2.32M +76.62% | -3.45M +39.66% | -3.27M -278.05% | -6.24M -222.12% | -8.74M -276.19% | -9.68M -180.37% | -4.60M -40.93% | -29.27M -- |
Basic EPS | -- -- | 0 -- | -0.01 -- | -- -- | -- -- | 0 -- | 0 +100.00% | -- -- | 0 -- | -0.01 -- | -1.66 -- | -- -- | -1.15 -- | -0.49 -4800.00% | -1.07 +35.54% | -0.23 -- | -0.37 +67.83% | -0.36 +26.53% | -0.15 +85.98% | -0.16 +30.43% | -0.15 +59.46% | -0.12 +66.67% | -0.19 -26.67% | -0.16 -- | -0.26 -73.33% | -0.14 -16.67% | -1.88 -889.47% | -0.04 +75.00% | -3.43 -1219.23% | -0.08 +42.86% | -4.37 -132.45% | -2.33 -5725.00% | -3.53 -2.92% | -3.23 -3937.50% | -1.25 +71.40% | -10.34 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.88 -- | -- -- | -3.43 -- | -0.08 -- | -4.37 -132.45% | -- -- | -3.53 -2.92% | -3.23 -3937.50% | -1.25 +71.40% | -- -- |
Diluted EPS | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.01 -- | -1.66 -- | -- -- | -1.15 -- | -0.49 -4800.00% | -1.07 +35.54% | -- -- | -0.37 +67.83% | -0.36 +26.53% | -0.15 +85.98% | -- -- | -0.15 +59.46% | -0.12 +66.67% | -0.19 -26.67% | -- -- | -0.26 -73.33% | -0.14 -16.67% | -1.88 -889.47% | -- -- | -3.43 -1219.23% | -0.08 +42.86% | -4.37 -132.45% | -- -- | -3.53 -2.92% | -3.23 -3937.50% | -1.25 +71.40% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.88 -- | -- -- | -3.43 -- | -0.08 -- | -4.37 -132.45% | -- -- | -3.53 -2.92% | -3.23 -3937.50% | -1.25 +71.40% | -- -- |
You can ask Aime
What guidance did Quantum BioPharma's management provide for the next earnings period?Did Quantum BioPharma beat or miss consensus estimates last quarter?What were the key takeaways from Quantum BioPharma’s earnings call?What does Quantum BioPharma do and what are its main business segments?What were the key takeaways from Quantum BioPharma's earnings call?What factors drove the changes in Quantum BioPharma's revenue and profit?What is Quantum BioPharma's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Quantum BioPharma year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
